Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Joao Victor Alessi"'
Autor:
Mark Awad, Giuseppe Lamberti, Lynette Sholl, Joao Victor Alessi, Stephanie Alden, Victor Vaz, Adriana Barrichello
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/8df1ae61f90146d7858e2011123c9746
Autor:
Mark Awad, Gonzalo Recondo, Giuseppe Lamberti, Scott Rodig, Joao Victor Alessi, Victor Vaz, Adriana Barrichello, Yvonne Lin-Liu, Hersh Gupta, Xinan Wang, Andrew Cherniack, Kristen Felt
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/c19039c2b2f343709f753ff67eb72ede
Autor:
Marcelo V. Negrao, Haniel A. Araujo, Giuseppe Lamberti, Alissa J. Cooper, Neal S. Akhave, Teng Zhou, Lukas Delasos, J Kevin. Hicks, Mihaela Aldea, Gabriele Minuti, Jacobi Hines, Jacqueline V. Aredo, Michael J. Dennis, Turja Chakrabarti, Susan C. Scott, Paolo Bironzo, Matthias Scheffler, Petros Christopoulos, Albrecht Stenzinger, Jonathan W. Riess, So Yeon Kim, Sarah B. Goldberg, Mingjia Li, Qi Wang, Yun Qing, Ying Ni, Minh Truong Do, Richard Lee, Biagio Ricciuti, Joao Victor. Alessi, Jing Wang, Blerina Resuli, Lorenza Landi, Shu-Chi Tseng, Mizuki Nishino, Subba R. Digumarthy, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, Ara A Vaporciyan, George R. Blumenschein, Jianjun Zhang, Dwight H. Owen, Collin M. Blakely, Giannis Mountzios, Catherine A. Shu, Christine M. Bestvina, Marina Chiara. Garassino, Kristen A. Marrone, Jhanelle E. Gray, Sandip Pravin. Patel, Amy L. Cummings, Heather A. Wakelee, Juergen Wolf, Giorgio Vittorio. Scagliotti, Federico Cappuzzo, Fabrice Barlesi, Pradnya D. Patil, Leylah Drusbosky, Don L. Gibbons, Funda Meric-Bernstam, J. Jack Lee, John V. Heymach, David S. Hong, Rebecca S. Heist, Mark M. Awad, Ferdinandos Skoulidis
Publikováno v:
Cancer Discovery.
Molecular modifiers of KRAS G12C inhibitor (KRAS G12Ci) efficacy in advanced KRAS G12C-mutant NSCLC are poorly defined. In a large unbiased clinico-genomic analysis of 424 NSCLC patients, we identified and validated co-alterations in KEAP1, SMARCA4 a
Autor:
Chiara Ambrogio, Pasi A. Jänne, Mark M. Awad, Prafulla C. Gokhale, David Santamaria, Marie-Julie Nokin, Elodie Richard, Yunhan Chen, Kshiti H. Dholakia, Jens Köhler, Amanda J. Redig, Chhayheng Chhoeu, Joao Victor Alessi, Yue Xu, Jiaqi Li, Heidi M. Haikala, Mika Lin, Haiyun Wang, Raymond Paranal, Xinan Wang, Yoonji Eum, Enrico Patrucco, Alessia Mira, Jeffrey J. Okoro, Jieun Son, Biagio Ricciuti
Supplementary Data from Comparative Analysis and Isoform-Specific Therapeutic Vulnerabilities of KRAS Mutations in Non–Small Cell Lung Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e908ecdb4bf36d5ab7cc98336d10d7d
https://doi.org/10.1158/1078-0432.22484111.v1
https://doi.org/10.1158/1078-0432.22484111.v1
Autor:
Chiara Ambrogio, Pasi A. Jänne, Mark M. Awad, Prafulla C. Gokhale, David Santamaria, Marie-Julie Nokin, Elodie Richard, Yunhan Chen, Kshiti H. Dholakia, Jens Köhler, Amanda J. Redig, Chhayheng Chhoeu, Joao Victor Alessi, Yue Xu, Jiaqi Li, Heidi M. Haikala, Mika Lin, Haiyun Wang, Raymond Paranal, Xinan Wang, Yoonji Eum, Enrico Patrucco, Alessia Mira, Jeffrey J. Okoro, Jieun Son, Biagio Ricciuti
Purpose:Activating missense mutations of KRAS are the most frequent oncogenic driver events in lung adenocarcinoma (LUAD). However, KRAS isoforms are highly heterogeneous, and data on the potential isoform-dependent therapeutic vulnerabilities are st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a622d7dd524d9e4c7db5d7f6e4ccfdc
https://doi.org/10.1158/1078-0432.c.6531326
https://doi.org/10.1158/1078-0432.c.6531326
Autor:
Biagio Ricciuti, Giuseppe Lamberti, Joao Victor Alessi, Federica Pecci, Alessandro Di Federico, Xinan Wang, Adriana Barrichello, Victor Vaz, Andy Pangilinan, Danielle Haradon, Lee Elinton, Mizuki Nishino, Scott Rodig, Lynette Sholl, Mark Awad
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Alessio Cortellini, Adriana Barrichello, Joao Victor Alessi, Biagio Ricciuti, Victor Vatz, Thomas Newsom-Davis, Joanne Evans, Giuseppe Lamberti, Federica Pecci, Patrizia Viola, Antonio D'Alessio, Claudia Fulgenzi, Mark Awad, David Pinato
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Giuseppe Lamberti, Biagio Ricciuti, Victor Vaz, Joao Victor Alessi, Federica Pecci, Alessandro Di Federico, Mark Awad
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Stefan Groha, Sarah Abou Alaiwi, Wenxin Xu, Vivek Naranbhai, Amin H. Nassar, Ziad Bakouny, Elio Adib, Pier V. Nuzzo, Andrew L. Schmidt, Chris Labaki, Talal El Zarif, Biagio Ricciuti, Joao Victor Alessi, David A. Braun, Sachet A. Shukla, Tanya E. Keenan, Eliezer Van Allen, Mark M. Awad, Michael Manos, Osama Rahma, Leyre Zubiri, Alexandra-Chloe Villani, Christian Hammer, Zia Khan, Kerry Reynolds, Yevgeniy Semenov, Deborah Schrag, Kenneth L. Kehl, Matthew L. Freedman, Toni K. Choueiri, Alexander Gusev
Immune checkpoint inhibitors (ICIs) have yielded remarkable responses in patients across multiple cancer types, but often lead to immune related adverse events (irAEs). Although a germline cause for irAEs has been hypothesized, no systematic genome w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a647d724ca325a7b74c97efbba0d738c
https://zenodo.org/record/6800429
https://zenodo.org/record/6800429
Autor:
Stefan Groha, Sarah Abou Alaiwi, Wenxin Xu, Vivek Naranbhai, Amin H. Nassar, Ziad Bakouny, Talal El Zarif, Renee Maria Saliby, Guihong Wan, Ahmad Rajeh, Elio Adib, Pier V. Nuzzo, Andrew L. Schmidt, Chris Labaki, Biagio Ricciuti, Joao Victor Alessi, David A. Braun, Sachet A. Shukla, Tanya E. Keenan, Eliezer Van Allen, Mark M. Awad, Michael Manos, Osama Rahma, Leyre Zubiri, Alexandra-Chloe Villani, Benjamin Fairfax, Christian Hammer, Zia Khan, Kerry Reynolds, Yevgeniy Semenov, Deborah Schrag, Kenneth L. Kehl, Matthew L. Freedman, Toni K. Choueiri, Alexander Gusev
Publikováno v:
Nature medicine.
Immune checkpoint inhibitors (ICIs) have yielded remarkable responses but often lead to immune-related adverse events (irAEs). Although germline causes for irAEs have been hypothesized, no individual variant associated with developing irAEs has been